CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Open-market sale SVP, Chief Business Officer sold 1,398 shares at $19.64 ($27,457)
- 4 Open-market sale SVP, Chief Business Officer sold 5,000 shares at $19.30 ($96,500)
- 4 Open-market sale SVP, Chief Business Officer sold 5,000 shares at $15.00 ($75,000)
- 4 Open-market buy Director bought 1,034,482 shares at $14.50 ($14,999,989)
- 4 Open-market sale SVP, Chief Business Officer sold 1,399 shares at $14.26 ($19,947)
- 4 Open-market sale SVP, General Counsel, Sec. sold 1,554 shares at $14.26 ($22,156)
- 4 Open-market sale Director sold 990 shares at $14.27 ($14,127)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Chief Business Officer sold 1,401 shares at $9.18 ($12,858)
- 4 Open-market sale Director sold 991 shares at $9.20 ($9,119)
- 4 Open-market sale SVP, General Counsel, Sec. sold 1,556 shares at $9.18 ($14,280)
- 4 Grant or award SVP, Chief Business Officer acquired 39,500 shares (grant or award)
Page 13 of 19 · 378 filings